Literature DB >> 17826272

Acetabular reconstruction using a cementless cup and hydroxyapatite granules: 3- to 8-year clinical results.

Akihiro Sudo1, Masahiro Hasegawa, Aki Fukuda, Goshin Kawamura, Makoto Muraki, Atsumasa Uchida.   

Abstract

We investigated 17 patients undergoing consecutive revision or conversion total hip arthroplasties with a cementless cup for acetabular bone defects. Patients were all women and the average age at the time of surgery was 61.2 years. All bone defects were filled and packed with porous hydroxyapatite (HA) granules. The average follow-up was 5.6 years (range, 3-8 years). The average Merle d'Aubigné functional hip score was 15.6 at the latest follow-up vs 11.6 before surgery. No patients needed additional revision surgery. In 4 cases in which a superior deficiency had been covered with HA granules, the cup migrated superior to the host bone but without any detrimental effect. The remaining 13 cases showed no migration of the cup. We conclude that acetabular reconstruction with a cementless cup and HA granules seems to provide encouraging intermediate results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826272     DOI: 10.1016/j.arth.2006.09.011

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

Review 1.  [Acetabular defect reconstruction in revision surgery of the hip. Autologous, homologous or metal?].

Authors:  S Gravius; G Pagenstert; O Weber; N Kraska; H Röhrig; D C Wirtz
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

2.  Modular acetabular reconstructive cup in acetabular revision total hip arthroplasty at a minimum ten year follow-up.

Authors:  Takashi Sakai; Kenji Ohzono; Takashi Nishii; Masaki Takao; Hidenobu Miki; Nobuo Nakamura; Nobuhiko Sugano
Journal:  Int Orthop       Date:  2013-02-20       Impact factor: 3.075

3.  Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection.

Authors:  H Henry Lai; Eric A Hurtado; Rodney A Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.